about
Common FXIII and fibrinogen polymorphisms in abdominal aortic aneurysms.Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen.Inhibition of plasmin-mediated TAFI activation may affect development but not progression of abdominal aortic aneurysms.Characterization of the I4399M variant of apolipoprotein(a): implications for altered prothrombotic properties of lipoprotein(a).The (Patho)physiology of Fibrinogen γ'.The prothrombotic state in paroxysmal nocturnal hemoglobinuria: a multifaceted source.Atherothrombosis and Thromboembolism: Position Paper from the Second Maastricht Consensus Conference on Thrombosis.Sensing adhesion forces between erythrocytes and γ' fibrinogen, modulating fibrin clot architecture and function.Thrombin-activatable fibrinolysis inhibitor in human abdominal aortic aneurysm disease.The 95RGD97 sequence on the Aα chain of fibrinogen is essential for binding to its erythrocyte receptor.Thrombin and fibrinogen γ' impact clot structure by marked effects on intrafibrillar structure and protofibril packing.The alpha-2-antiplasmin Arg407Lys polymorphism is associated with abdominal aortic aneurysm.A fibrin biofilm covers the blood clot and protects from microbial invasion.Impact of γ'γ' fibrinogen interaction with red blood cells on fibrin clotsReflections of Research Getting to the heart of the problem, by Fraser MacraeAffimer proteins as a tool to modulate fibrinolysis, stabilize the blood clot and reduce bleeding complicationsAssessment and determinants of whole blood and plasma fibrinolysis in patients with mild bleeding symptomsRecurrent venous thromboembolism patients form clots with lower elastic modulus than those formed by patients with non-recurrent diseasePatients with paroxysmal nocturnal hemoglobinuria demonstrate a prothrombotic clotting phenotype which is improved by complement inhibition with eculizumab
P50
Q35407463-6846B5D0-4A61-4176-995B-C46C1F056088Q35911484-FFD0D17A-7490-4DF5-993E-A74CF4C82C02Q36363159-1EF6D580-58CF-4420-AE6D-BD6EC0B9A961Q38717170-D4285949-EE18-46F8-8496-2883650B1733Q38806310-6DC51B70-64CB-44FB-ADE9-0C1268E9F965Q49791317-412686ED-1AB1-4445-8A07-7E84BF0DCAB5Q50077941-428D8077-971F-4267-A10E-59D71807F8B7Q50148651-E0E9A2E5-35D7-4390-AF1F-71C4D5E5F354Q51823725-FC6BA31A-F008-43B5-86C4-CAF1ED689ACFQ52584483-56FDFF9F-9559-4D5F-82F7-352EB9B59142Q52820087-58251177-7FBF-4D4B-A1F3-A498EC36FC2AQ52839160-70A1AD56-E86B-4EC3-9E32-01FF1A244AF7Q54221992-F583FD02-0AA2-4626-A48E-A676DCDE232EQ57471920-AE247007-A82D-4EB2-ADF6-79D1DB6BE59CQ58420507-C5289C1D-61C3-4548-94E6-2B29B7A6C20DQ61821433-214D8603-4349-4223-91EE-EBA3CD2D5B37Q61843407-2CCBE046-8C3E-477D-AC76-0AA7A8A8B5ECQ64115907-B96ABD47-1D4A-4AA1-8D2F-4FCD9E162352Q92079917-E464A1C3-FA89-4D16-9D05-8241D32F03E4
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Fraser L Macrae
@ast
Fraser L Macrae
@en
Fraser L Macrae
@es
Fraser L Macrae
@nl
Fraser L Macrae
@sl
type
label
Fraser L Macrae
@ast
Fraser L Macrae
@en
Fraser L Macrae
@es
Fraser L Macrae
@nl
Fraser L Macrae
@sl
prefLabel
Fraser L Macrae
@ast
Fraser L Macrae
@en
Fraser L Macrae
@es
Fraser L Macrae
@nl
Fraser L Macrae
@sl
P106
P1153
56281198400
P21
P31
P496
0000-0002-7092-0422